Growth Metrics

Soleno Therapeutics (SLNO) EBIT Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.69%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 75.16%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -347.04%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 80.62%
7 Evaxion A 64.16 Bn 64.14 Bn - 1.27%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 8.65%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,386.07%
10 Soleno Therapeutics 2.76 Bn 2.51 Bn 93.41 Mn 168.38%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 168.38%
Dec 31, 2025 166.95%
Sep 30, 2025 127.56%
Jun 30, 2025 73.76%
Mar 31, 2025 -94.86%
Dec 31, 2024 -324.99%
Sep 30, 2024 -672.61%
Jun 30, 2024 -188.39%
Mar 31, 2024 -177.19%
Dec 31, 2023 -147.95%
Sep 30, 2023 -66.51%
Jun 30, 2023 -27.20%
Mar 31, 2023 -46.70%
Dec 31, 2022 -86.94%
Sep 30, 2022 24.75%
Jun 30, 2022 38.85%
Mar 31, 2022 36.95%
Dec 31, 2021 62.28%
Sep 30, 2021 -5.46%
Jun 30, 2021 0.96%
Mar 31, 2021 1.36%
Dec 31, 2020 -17.85%
Sep 30, 2020 -28.11%
Jun 30, 2020 -99.06%
Mar 31, 2020 -86.46%
Dec 31, 2019 -91.00%
Sep 30, 2019 -58.15%
Jun 30, 2019 -64.75%
Mar 31, 2019 -43.25%
Dec 31, 2018 32.01%
Sep 30, 2018 -47.40%
Jun 30, 2018 -14.99%
Mar 31, 2018 -153.10%
Dec 31, 2017 -183.62%
Sep 30, 2017 -33.69%
Jun 30, 2017 -29.32%
Mar 31, 2017 67.79%
Dec 31, 2016 47.73%
Sep 30, 2016 38.17%
Jun 30, 2016 24.61%
Mar 31, 2016 -75.72%
Dec 31, 2015 -89.99%
Sep 30, 2015 -140.59%
Jun 30, 2015 -132.90%
Mar 31, 2015 -254.68%
Dec 31, 2014 -229.72%
Sep 30, 2014 -33.23%